Chemerin and its receptor, chemokine-like receptor 1 (CmklR1), are associated with
chemotaxis, inflammation, and endothelial function, especially in metabolic syndrome …

Introduction Chemerin as an inflammatory biomarker has gained attention in its biomarker
capability. Several studies measured its levels in chronic kidney disease (CKD), as one of …

The potential involvement of chemerin in cardiovascular and renal dysfunction has recently
been acknowledged. There are indeed many links between this protein and inflammation …

Diabetic nephropathy (DN) is characterized by inflammation of renal tissue. Glomerular
endothelial cells (GEnCs) play an important role in inflammation and protein leakage in …

Objective Chemerin has been found to be highly expressed in the kidneys of rodents and
has been suggested to affect metabolic syndrome (MetS)‐related phenotypes which are in …

Background Circulating levels of chemerin are significantly higher in hypertensive patients
and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 …

Chemerin acting via its distinct G protein-coupled receptor CMKLR1 (ChemR23), is a novel
adipokine, circulating levels of which are raised in inflammatory states. Chemerin shows …

Chemerin is shown to be associated with inflammation which is involved in the
pathogenesis of diabetic nephropathy. This study aims to determine whether rosiglitazone …

Obesity is associated with a series of health problems. Adipocytes are a huge repository of
energy as well as an important source of many adipokines. In obesity, adipocytes are …

Background Chemerin is an adipokine that signals through the G protein‐coupled receptor
ChemR23 and is associated with inflammation, glucose homeostasis, lipid metabolism and …